Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-wee... von Merrill, J T, van Vollenhoven, R F, Buyon, J P, Furie, R A, Stohl, W, Morgan-Cox, M, Dickson, C, Anderson, P W, Lee, C, Berclaz, P-Y, Dörner, T

Volltext

Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo‐controlled trial von van Vollenhoven, R. F., Kinnman, N., Vincent, E., Wax, S., Bathon, J.

Volltext

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendation... von Nam, J L, Winthrop, K L, van Vollenhoven, R F, Pavelka, K, Valesini, G, Hensor, E M A, Worthy, G, Landewé, R, Smolen, J S, Emery, P, Buch, M H

Volltext

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial von Tak, P P, Rigby, W F, Rubbert-Roth, A, Peterfy, C G, van Vollenhoven, R F, Stohl, W, Hessey, E, Chen, A, Tyrrell, H, Shaw, T M

Volltext

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies von Mosca, M, Tani, C, Aringer, M, Bombardieri, S, Boumpas, D, Brey, R, Cervera, R, Doria, A, Jayne, D, Khamashta, M A, Kuhn, A, Gordon, C, Petri, M, Rekvig, O P, Schneider, M, Sherer, Y, Shoenfeld, Y, Smolen, J S, Talarico, R, Tincani, A, van Vollenhoven, R F, Ward, M M, Werth, V P, Carmona, L

Volltext

Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled... von van Vollenhoven, R. F., Wax, S., Li, Y., Tak, P. P.

Volltext

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions von Van den Bosch, F, Manger, B, Goupille, P, McHugh, N, Rødevand, E, Holck, P, van Vollenhoven, R F, Leirisalo-Repo, M, FitzGerald, O, Kron, M, Frank, M, Kary, S, Kupper, H

Volltext

Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis : results fr... von Hambardzumyan, K., Hermanrud, C., Marits, P., Vivar, N., Ernestam, S., Wallman, J. K., van Vollenhoven, R. F., Fogdell-Hahn, A., Saevarsdottir, S.

Volltext

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients von Choi, M Y, Clarke, A E, St Pierre, Y, Hanly, J G, Urowitz, M B, Romero-Diaz, J, Gordon, C, Bae, S-C, Bernatsky, S, Wallace, D J, Merrill, J T, Isenberg, D A, Rahman, A, Ginzler, E M, Petri, M, Bruce, I N, Dooley, M A, Fortin, P, Gladman, D D, Sanchez-Guerrero, J, Steinsson, K, Ramsey-Goldman, R, Khamashta, M A, Aranow, C, Alarcón, G S, Manzi, S, Nived, O, Zoma, A A, van Vollenhoven, R F, Ramos-Casals, M, Ruiz-Irastorza, G, Lim, S S, Kalunian, K C, Inanc, M, Kamen, D L, Peschken, C A, Jacobsen, S, Askanase, A, Buyon, J, Mahler, M, Fritzler, M J

Volltext

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiori... von van Herwaarden, Noortje, van der Maas, Aatke, Minten, Michiel J M, van den Hoogen, Frank H J, Kievit, Wietske, van Vollenhoven, Ronald F, Bijlsma, Johannes W J, van den Bemt, Bart J F, den Broeder, Alfons A

Volltext

Prevalence of coeliac disease in patients with rheumatoid arthritis and juvenile idiopathic arthritis: a systematic review and meta-analysis von Forss, Anders, Sotoodeh, Adonis, van Vollenhoven, Ronald F, Ludvigsson, Jonas F

Volltext

Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky von Rusman, T., van Vollenhoven, R. F., van der Horst-Bruinsma, I. E.

Volltext

Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study von WEINBLATT, Michael E, FLEISCHMANN, Roy, GOEL, Niti, DAVIES, Owen R, DOUGADOS, Maxime, HUIZINGA, Tom W. J, EMERY, Paul, POPE, Janet, MASSAROTTI, Elena M, VOLLENHOVEN, Ronald F. Van, WOLLENHAUPT, Jürgen, BINGHAM, Clifton O, DUNCAN, Ben

Volltext

Dysregulated Fcγ receptor IIa‐induced cytokine production in dendritic cells of lupus nephritis patients von Newling, M., Fiechter, R. H., Sritharan, L., Hoepel, W., Burgsteden, J. A., Hak, A. E., Vollenhoven, R. F., Sande, M. G. H., Baeten, D. L. P., den Dunnen, J.

Volltext

DRESS syndrome and reversible liver function abnormalities in patients with systemic lupus erythematosus treated with the highly selective JAK-1 inhibitor GSK2586184 von van Vollenhoven, R F, Layton, M, Kahl, L, Schifano, L, Hachulla, E, Machado, D, Staumont-Sallé, D, Patel, J

Volltext

Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect von van Vollenhoven, R F, Brannemark, S, Klareskog, L

Volltext

Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus von Kahl, L, Patel, J, Layton, M, Binks, M, Hicks, K, Leon, G, Hachulla, E, Machado, D, Staumont-Sallé, D, Dickson, M, Condreay, L, Schifano, L, Zamuner, S, van Vollenhoven, R F

Volltext

Treatment Algorithms in Systemic Lupus Erythematosus von Muangchan, Chayawee, van Vollenhoven, Ronald F., Bernatsky, Sasha R., Smith, C. Douglas, Hudson, Marie, Inanç, Murat, Rothfield, Naomi F., Nash, Peter T., Furie, Richard A., Senécal, Jean‐Luc, Chandran, Vinod, Burgos‐Vargas, Ruben, Ramsey‐Goldman, Rosalind, Pope, Janet E.

Volltext

Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies von Jonsdottir, T, Forslid, J, van Vollenhoven, A, Harju, A, Brannemark, S, Klareskog, L, van Vollenhoven, R F

Volltext

Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity von Ippolito, A, Wallace, DJ, Gladman, D, Fortin, PR, Urowitz, M, Werth, V, Costner, M, Gordon, C, Alarcón, GS, Ramsey-Goldman, R, Maddison, P, Clarke, A, Bernatsky, S, Manzi, S, Bae, S-C, Merrill, JT, Ginzler, E, Hanly, JG, Nived, O, Sturfelt, G, Sanchez-Guerrero, J, Bruce, I, Aranow, C, Isenberg, D, Zoma, A, Magder, LS, Buyon, J, Kalunian, K, Dooley, MA, Steinsson, K, Vollenhoven, RF van, Stoll, T, Weisman, M, Petri, M

Volltext